05/07/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.20 |
Details |
Payment from |
United Therapeutics Corporation |
Payment Record ID |
615264305 |
|
02/12/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.20 |
Details |
Payment from |
United Therapeutics Corporation |
Payment Record ID |
615264299 |
|
10/12/2018 |
Research |
Cash or cash equivalent |
Drug |
$26.16 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602007087 |
|
10/12/2018 |
Research |
In-kind items and services |
Drug |
$39.15 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602007083 |
|
10/12/2018 |
Research |
In-kind items and services |
Drug |
$39.61 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602007081 |
|
10/12/2018 |
Research |
In-kind items and services |
Drug |
$23.77 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602007077 |
|
10/11/2018 |
Research |
Cash or cash equivalent |
Drug |
$12.24 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602003211 |
|
10/11/2018 |
Research |
In-kind items and services |
Drug |
$18.97 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602003205 |
|
10/11/2018 |
Research |
In-kind items and services |
Drug |
$87.27 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602003203 |
|
10/11/2018 |
Research |
In-kind items and services |
Drug |
$59.56 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602003197 |
|
10/11/2018 |
Research |
In-kind items and services |
Drug |
$39.61 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602003191 |
|
10/11/2018 |
Research |
In-kind items and services |
Drug |
$23.77 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602003187 |
|
10/10/2018 |
Research |
Cash or cash equivalent |
Drug |
$16.76 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602002067 |
|
10/10/2018 |
Research |
Cash or cash equivalent |
Drug |
$31.56 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602002061 |
|
10/10/2018 |
Research |
In-kind items and services |
Drug |
$79.23 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602002057 |
|
10/10/2018 |
Research |
In-kind items and services |
Drug |
$207.13 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602002053 |
|
10/10/2018 |
Research |
In-kind items and services |
Drug |
$409.40 |
Details |
Payment from |
SANOFI US SERVICES INC. |
Paymment Research Study |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O |
Clinical Trials Gov ID |
NCT03546907 |
Payment Record ID |
602002047 |
|
05/11/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.07 |
Details |
Payment from |
GlaxoSmithKline, LLC. |
Payment Record ID |
594670216 |
|
08/14/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$17.66 |
Details |
Payment from |
United Therapeutics Corporation |
Payment Record ID |
510339001 |
|
04/10/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$15.23 |
Details |
Payment from |
United Therapeutics Corporation |
Payment Record ID |
510338999 |
|
03/03/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$35.00 |
Details |
Payment from |
Olympus Corporation of the Americas |
Payment Record ID |
505598677 |
|
03/03/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$17.95 |
Details |
Payment from |
Olympus Corporation of the Americas |
Payment Record ID |
505598583 |
|
03/02/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$357.20 |
Details |
Payment from |
Olympus Corporation of the Americas |
Payment Record ID |
505598535 |
|
03/02/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$136.40 |
Details |
Payment from |
Olympus Corporation of the Americas |
Payment Record ID |
505598497 |
|
03/02/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$118.77 |
Details |
Payment from |
Olympus Corporation of the Americas |
Payment Record ID |
505598439 |
|
03/03/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$62.04 |
Details |
Payment from |
Olympus Corporation of the Americas |
Payment Record ID |
505598387 |
|
03/14/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.68 |
Details |
Payment from |
Gilead Sciences Inc |
Payment Record ID |
480382883 |
|
01/03/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.47 |
Details |
Payment from |
Gilead Sciences Inc |
Payment Record ID |
480382881 |
|
04/05/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.83 |
Details |
Payment from |
GlaxoSmithKline, LLC. |
Payment Record ID |
479642537 |
|
02/14/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.75 |
Details |
Payment from |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Payment Record ID |
466076418 |
|
01/24/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.64 |
Details |
Payment from |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Payment Record ID |
466076411 |
|
01/18/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.60 |
Details |
Payment from |
Alexion Pharmaceuticals, Inc. |
Payment Record ID |
463190437 |
|
03/01/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$17.36 |
Details |
Payment from |
BOSTON SCIENTIFIC CORPORATION |
Payment Record ID |
455538137 |
|
01/31/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$18.44 |
Details |
Payment from |
BOSTON SCIENTIFIC CORPORATION |
Payment Record ID |
455538135 |
|
04/17/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.54 |
Details |
Payment from |
Janssen Pharmaceuticals, Inc |
Payment Record ID |
449212965 |
|
12/12/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.06 |
Details |
Payment from |
United Therapeutics Corporation |
Payment Record ID |
415799663 |
|
09/12/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$10.22 |
Details |
Payment from |
United Therapeutics Corporation |
Payment Record ID |
415799661 |
|
05/09/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.50 |
Details |
Payment from |
United Therapeutics Corporation |
Payment Record ID |
415799655 |
|
11/29/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$18.59 |
Details |
Payment from |
Circassia Pharmaceuticals Inc |
Payment Record ID |
412820884 |
|
06/28/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.36 |
Details |
Payment from |
GlaxoSmithKline, LLC. |
Payment Record ID |
396838453 |
|
03/01/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$10.88 |
Details |
Payment from |
GlaxoSmithKline, LLC. |
Payment Record ID |
396838419 |
|
11/22/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.54 |
Details |
Payment from |
Gilead Sciences Inc |
Payment Record ID |
392585716 |
|
10/18/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.10 |
Details |
Payment from |
Gilead Sciences Inc |
Payment Record ID |
392585676 |
|
09/13/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.75 |
Details |
Payment from |
Gilead Sciences Inc |
Payment Record ID |
392585638 |
|
03/29/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.50 |
Details |
Payment from |
Gilead Sciences Inc |
Payment Record ID |
392585578 |
|
02/23/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.10 |
Details |
Payment from |
Gilead Sciences Inc |
Payment Record ID |
392585540 |
|
01/26/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.12 |
Details |
Payment from |
Gilead Sciences Inc |
Payment Record ID |
392585500 |
|
01/05/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.28 |
Details |
Payment from |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Payment Record ID |
381453976 |
|
01/12/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.60 |
Details |
Payment from |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Payment Record ID |
381453966 |
|
03/22/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.20 |
Details |
Payment from |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Payment Record ID |
381453958 |
|
10/12/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.50 |
Details |
Payment from |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Payment Record ID |
381453946 |
|
01/22/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$108.52 |
Details |
Payment from |
Covidien Sales LLC |
Payment Record ID |
372127872 |
|
02/02/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$20.21 |
Details |
Payment from |
Regeneron Healthcare Solutions, Inc. |
Payment Record ID |
366540192 |
|